Enlicitid Lowers LDL Cholesterol Significantly in High-Risk Patients: What You Need to Know
A new investigational drug, enlicitide, has shown significant LDL-cholesterol reduction in high-risk patients who do not respond adequately to statins, according to recent clinical data. Developed to target PCSK9 via ... Read More